FDA Approved Pill

Lybrel is a first of its kind birth control pill that was approved for use by the U.S. Food and Drug Administration on May 22, 2007.Lybrel has been approved by FDA as a pill that prevents pregnancy. The new contraceptive, Lybrel, comes in a 28 day-pill pack with low-dose combination tablets that contain 90 micrograms of a progestin, levonorgestrel, and 20 micrograms of an estrogen, ethinyl estradiol, which are active ingredients available in other approved oral contraceptives.

Continuous contraception works the same way as the 21 days on-seven days off cycle. It stops the body's monthly preparation for pregnancy by lowering the production of hormones that make pregnancy possible. Lybrel is manufactured by Wyeth of Philadelphia, PA.

Lybrel is the recent most advanced and unique combination birth control pill which is the first extended-cycle oral contraceptive. Lybrel has specially been designed and formulated for providing the effective dose of hormones on daily basis. Lybrel is said to completely cease the menstrual periods in females for the whole year. The pill, as it is categorized, contains extremely low dose of Levonorgestrel - 90 mcg and Ethyl Estradiol - 20mcg and is the continuous non cyclic combination oral contraceptive.